Back to series
#ESC2021 Hotline: PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease
MedShr Editor
MedShr

#ESC2021 Hotline: PRONOUNCE: comparing cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and cardiovascular disease

MedShr Editor

#ESC2021 Hotline Presentation

Sign up to start learning
,